Technology
Health
Pharmaceutical
MYOS RENS
$1.439876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.05 (-3.38%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell MYOS RENS and other stocks, options, ETFs, and crypto commission-free!
About
MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of therapeutic products, nutritional supplements, and other technologies aimed at improving the health and performance of muscle tissue. It offers bionutrition products and biotherapeutic research. Read More Bionutrition products involves Re Muscle Health, which seeks to rebuild, rejuvenate, and maintain lean muscles. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.
Employees
10
Headquarters
Cedar Knolls, New Jersey
Founded
2007
Market Cap
11.06M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
202.47K
High Today
$1.48
Low Today
$1.40
Open Price
$1.47
Volume
2.57K
52 Week High
$2.50
52 Week Low
$1.04
Collections
Technology
Health
Pharmaceutical
Nutritional Supplements
Health And Wellness
2016 IPO
US
North America
News
Simply Wall StMar 14
Can We See Significant Insider Ownership On The MYOS RENS Technology Inc. (NASDAQ:MYOS) Share Register?
A look at the shareholders of MYOS RENS Technology Inc. (NASDAQ:MYOS) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. Warren Buffett said that he likes ‘a business with enduring competitive advantages that is run by able and owner-oriented people’. So it’s nice to see some insider ownership, because it may suggest that management is owner-oriented. MYOS RENS Technology is a smaller comp...
Price Paid on Robinhood
27% Lower
Right Now
52 Week Low
$1.04
Average Price Paid
$1.96
52 Week High
$2.50
Earnings
-$0.19
-$0.13
-$0.06
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.13 per share
Actual
Expected Mar 27, After Hours